Therapeutic effect of a novel long-actingGLP-1/GIP/Glucagon triple agonist (HM15211) in CDHFD-induced NASH and fibrosis mice

被引：0
|
作者：
Choi, J. [1 ]
Jo, H. [1 ]
Kim, J. [1 ]
Kwon, H. [1 ]
Lee, J. [1 ]
Bae, S. [1 ]
Kim, D. [1 ]
Lee, S. [1 ]
Choi, I. [1 ]
机构：
[1] Hanmi Pharm Co Ltd, Hwaseong Si, Gyeonggi Do, South Korea
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
127
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in CDHFD-Induced NASH and Fibrosis Mice
    Choi, Jaehyuk
    Kim, Jung Kuk
    Lee, Seon Myeong
    Kwon, Hyunjoo
    Lee, Jongsoo
    Bae, Sungmin
    Kim, Daejin
    Choi, In Young
    DIABETES, 2020, 69
  • [2] THERAPEUTIC EFFECT OF A NOVEL LONG-ACTING GLUCAGON/GIP/GLP-1 TRIPLE AGONIST (HM15211) IN CDHFD-INDUCED MOUSE MODEL OF NASH AND FIBROSIS MICE
    Choi, Jaehyuk
    Lee, Seon Myeong
    Kim, Jung Kuk
    Jo, Hyo Sang
    Lee, Jong Suk
    Kwon, Hyunjoo
    Bae, Sung Min
    Kim, Dae Jin
    Lee, Sang Hyun
    Choi, In Young
    HEPATOLOGY, 2020, 72 : 1039 - 1039
  • [3] Therapeutic effect of a novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) in NASH and fibrosis animal models
    Kim, J.
    Choi, I.
    Lee, J.
    Park, E.
    Kim, Y.
    Jung, S.
    Kim, S.
    DIABETOLOGIA, 2018, 61 : S61 - S62
  • [4] Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in a NASH and Fibrosis Animal Model
    Kim, Jung Kuk
    Lee, Jong Suk
    Kim, Daejin
    Park, Eunjin
    Kim, Young Hoon
    Choi, In Young
    DIABETES, 2019, 68
  • [5] Therapeutic effect of a novel long-acting GLP-1/GIP/glucagon triple agonist (HM15211) in animal models of NASH and fibrosis
    Kim, Jung Kuk
    Lee, Jong Suk
    Jo, Hyo Sang
    Kwon, Hyunjoo
    Park, Eun Jin
    Kim, Dae Jin
    Lee, Sang Hyun
    Kim, Young Hoon
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2020, 73 : S12 - S13
  • [6] Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in a NASH and Fibrosis Animal Model
    Choi, In Young
    Kim, Jung Kuk
    Lee, Jong Suk
    Park, Eunjin
    Kim, Young Hoon
    Jung, Sung Youb
    Kim, Sun Jin
    DIABETES, 2018, 67
  • [7] Effect of a novel long-acting GLP-1/GIP/Glucagon triple agonist (HM15211) in NASH and liver fibrosis animal models
    Kim, J.
    Lee, J.
    Kim, D.
    Park, E.
    Kim, Y.
    Choi, I.
    DIABETOLOGIA, 2019, 62 : S531 - S532
  • [8] Antifibrotic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in BDL-Induced Liver Fibrosis Mice
    Kim, Jung Kuk
    Lee, Jong Suk
    Kwon, Hyunjoo
    Lee, Jongsoo
    Kim, Daejin
    Bae, Sungmin
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2020, 69
  • [9] Therapeutic Effect of a Novel Long-Acting GLP-1/GIP/Glucagon Triple Agonist (HM15211) in a Dyslipidemia Animal Model
    Choi, Jaehyuk
    Jo, Hyosang
    Kim, Jung Kuk
    Lee, Sang Don
    Lee, Sang Hyun
    Choi, In Young
    DIABETES, 2019, 68
  • [10] Multi-target engagement effect of a novel long-acting Glucagon/GIP/GLP-1 triple agonist, HM15211, in animal model of NASH/fibrosis
    Lee, Jong Suk
    Kim, Jung Kuk
    Lee, Seonmyeong
    Kim, Yohan
    Choi, Jaehyuk
    Kwon, Hyunjoo
    Park, Eun Jin
    Bae, Sung Min
    Lee, Sang Hyun
    Choi, In Young
    JOURNAL OF HEPATOLOGY, 2022, 77 : S468 - S469
12345